Riggins - Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends...

6:39
 
Share
 
Manage episode 191556697 series 1754503
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.
Full text - http://bit.ly/2yTX4uJ Oncotarget | Interview with Dr. Gregory J. Riggins from the Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD, USA talking about their featured cover paper published in Volume 8 Issue 46 titled "Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients". Facebook - http://bit.ly/2xznxjV Twitter - http://bit.ly/2xzWvsu LinkedIn - http://bit.ly/2xzJ6kc Pintrest - http://bit.ly/2xzX8SS Reddit - http://bit.ly/2hoxI0N www.Oncotarget.com

30 episodes available. A new episode about every 14 days averaging 15 mins duration .